Transcript : Baxter International Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 10
|
Market Closed –
|
5-day change | 1st Jan Change | ||
|
31.40 USD |
-1.01% |
|
+4.77% | +7.68% |
Published on 06/10/2025 at 19:50,
updated on 06/10/2025 at 20:05
Presenter Speech
David Roman (Analysts)
All right. Good morning, everyone. Very happy to start our — I think our next session, which features management from Baxter, Joel Grade, Executive Vice
|
Baxter International Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 10:40 AM |
Jun. 10 |
|
|
Baxter International Inc. to Offer Pieces’ Ai Platform to Hospital Care Teams |
Jun. 03 |
CI |
|
Goldman Sachs Adjusts Price Target on Baxter International to $37 From $39, Maintains Buy Rating |
Jun. 02 |
MT |
|
Baxter Launches Hemostat, A Room-Temperature Collagen Pad Approved for Hemostasis and Sealing, Suitable for Open Surgery and Minimally Invasive Surgical Procedures |
May. 20 |
CI |
|
Baxter International Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 08:40 AM |
May. 13 |
|
|
Declaration of Voting Results by Baxter International Inc |
May. 08 |
CI |
|
Tranche Update on Baxter International Inc.’s Equity Buyback Plan announced on July 25, 2012. |
May. 06 |
CI |
|
Wells Fargo Adjusts Baxter International Price Target to $33 From $36 |
May. 02 |
MT |
|
Citigroup Adjusts Price Target on Baxter International to $34 From $35 |
May. 02 |
MT |
|
Goldman Sachs Adjusts Price Target on Baxter International to $39 From $42 |
May. 02 |
MT |
|
Jefferies Adjusts Price Target on Baxter International to $35 From $38 |
May. 02 |
MT |
|
JPMorgan Adjusts Price Target on Baxter International to $34 From $36 |
May. 02 |
MT |
|
Evercore ISI Adjusts Baxter International Price Target to $44 From $45, Maintains Outperform Rating |
May. 01 |
MT |
|
Baxter tops quarterly estimates on strong demand for medical devices |
May. 01 |
RE |
|
Baxter International’s Q1 Adjusted Net Income Drops, Revenue Rises; Full-Year 2025 Guidance Revised |
May. 01 |
MT |
|
Baxter International Inc., Q1 2025 Earnings Call, May 01, 2025 |
May. 01 |
|
|
Baxter International Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 |
May. 01 |
CI |
|
Earnings Flash (BAX) Baxter Intl. Reports Q1 Adjusted EPS $0.62, vs. FactSet Est of $0.48 |
May. 01 |
MT |
|
(BAX) Baxter Intl. Expects Fiscal Year 2025 Adjusted EPS Range $2.47 – $2.55 |
May. 01 |
MT |
|
(BAX) Baxter Intl. Sees Q2 Adjusted EPS Range $0.59 – $0.63 |
May. 01 |
MT |
|
Earnings Flash (BAX) Baxter Intl. Posts Q1 Revenue $2.63B, vs. FactSet Est of $2.59B |
May. 01 |
MT |
|
Baxter International Inc. Provides Sales Guidance for the Second Quarter and Full Year 2025 |
May. 01 |
CI |
|
Baxter International Inc. Launches New Room Temperature Hemopatch Sealing Hemostat for Rapid and Convenient Application During Surgery |
Apr. 10 |
CI |
|
Citigroup Adjusts Baxter International Price Target to $35 From $37, Maintains Neutral Rating |
Apr. 07 |
MT |
|
Evercore ISI Adjusts Baxter International Price Target to $45 From $44, Maintains Outperform Rating |
Apr. 02 |
MT |
BAX: Dynamic Chart
Quarterly revenue – Rate of surprise
Select your edition
All financial news and data tailored to specific country editions
link
